Bluetongue vaccination in Europe

Expert Review of Vaccines

Volumn 9, Issue 9, 2010, Pages 989-991

  Zientara, Stéphan ^a   MacLachlan, Nigel James ^b   Calistri, Paolo ^c   Sanchez Vizcaino, Jose Manuel ^d   Savini, Giovanni ^c  

^a Healthy Pigs Production and Experimentation Section   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELL ABRUZZO E DEL MOLISE G CAPORALE   (Italy)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

bluetongue virus; emerging disease; Europe; inactivated vaccines; modified live virus vaccines

Indexed keywords

INACTIVATED VACCINE; LIVE VACCINE; VIRUS VACCINE; VIRUS VECTOR;

BLUETONGUE; BLUETONGUE ORBIVIRUS; EDITORIAL; EUROPE; GEOGRAPHIC DISTRIBUTION; INFECTION CONTROL; INFECTION PREVENTION; LIVESTOCK; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; VIRUS NEUTRALIZATION; VIRUS PARTICLE;

ANIMALS; BLUETONGUE; BLUETONGUE VIRUS; EUROPE; RUMINANTS; VACCINATION; VACCINES, ATTENUATED; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 77956484688     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.10.97     Document Type: Editorial

References (22)

1. Verwoerd D, Erasmus BJ. Bluetongue. In: Infectious Diseases of Livestock (2nd Edition). Coetzer JA, Tustin RC (Eds). Oxford University Press, Cape Town, South Africa, 1201-1220 (2004).
2. Maclachlan NJ, Drew CP, Darpel KE, Worwa G. The pathology and pathogenesis of bluetongue. J. Comp. Pathol. 141, 1-16 (2009).
3. Gibbs EP, Greiner EC. The epidemiology of bluetongue. Comp. Immunol. Microbiol. Infect. Dis. 17, 197-206 (1994).
4. Tabachnick WJ. Culicoides and the global epidemiology of bluetongue virus infection. Vet. Ital. 40, 145-150 (2004).
5. Toussaint JF, Vandenbussche F, Mast J et al. Bluetongue in northern Europe. Vet. Rec. 2, 327 (2006).
6. Mertens PP, Diprose J, Maan S, Singh KP, Attoui H, Samuel AR. Bluetongue virus replication, molecular and structural biology. Vet. Ital. 40, 426-437 (2004).
7. Hofmann MA, Renzullo S, Mader M, Chaignat V, Worva G, Thuer B. Genetic characterization of toggenburg orbivirus, a new bluetongue virus, from goats, Switzerland. Emerg. Infect. Dis. 14(12), 1855-1861 (2008).
8. Mellor PS, Carpenter S, Harrup L. Bluetongue in Europe and the Mediterranean basin: history of occurrence prior to 2006. Prev. Vet. Med. 87, 4-20 (2008).
9. Rodríguez-Sánchez B, Iglesias-Martín I, Martínez-Avilés M, Sánchez-Vizcaíno JM. Orbiviruses in the Mediterranean basin: updated epidemiological situation of bluetongue and new methods for the detection of BTV serotype 4. Transbound. Emerg. Dis. 55(5-6), 205-214 (2008)
10. Anonymous. Scientifc opinion of the scientifc panel on animal health and welfare on the EFSA self-mandate on bluetongue origin and occurence. EFSA J. 1-20, 2007.
11. Maan S, Maan NS, van Rijn PA et al. Full genome characterisation of bluetongue virus serotype 6 from The Netherlands 2008 and comparison to other feld and vaccine strains. PLoS One 5, e10323 (2010).
12. De Clercq K, Mertens P, De Leeuw I et al. Emergence of bluetongue serotypes in Europe, part 2: the occurrence of a BTV-11 strain in Belgium. Transbound. Emerg. Dis. 9-10, 355-361 (2009).
13. Patta C, Giovannini A, Rolesu S et al. Bluetongue vaccination in Europe: the Italian experience. Vet. Ital. 40(4), 601-610 (2004).
14. Noad R, Roy P. Bluetongue vaccines. Vaccine 27(Suppl. 4), D86-D89 (2009).
15. Boone JD, Balasuriya UB, Karaca K et al. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine 25, 672-678 (2007).
16. Savini G, Maclachlan NJ, Calistri P, Sanchez-Vizcaino JM, Zientara S. Vaccines against bluetongue in Europe. Comp. Immunol. Microbiol. Infect. Dis. 31, 101-120 (2007).
17. Di Emidio B, Nicolussi P, Patta C et al. Effcacy and safety studies on an inactivated vaccine against bluetongue virus serotype 2. Vet. Ital. 40, 640-644 (2004).
18. Roy P, French T, Erasmus BJ. Protective effcacy of virus-like particles for bluetongue disease. Vaccine 10, 28-32 (1992).
19. Caporale V, Giovannini A, Patta C, Calistri P, Nannini D, Santucci U. Vaccination in the control strategy of bluetongue in Italy. Dev. Biol. (Basel) 119, 113-127 (2004).
20. Dungu B, Gerdes T, Smit T. The use of vaccination in the control of bluetongue in southern Africa. Vet. Ital. 40, 616-622 (2004).
21. Ferrari G, De Liberato C, Scavia G et al. Active circulation of bluetongue vaccine virus serotype-2 among unvaccinated cattle in central Italy. Prev. Vet. Med. 68, 10-13 (2005).
22. Batten CA, Maan S, Shaw AE, Maan NS, Mertens PP. A European feld strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment. Virus Res. 137, 56-63 (2008).